What is LOPJLB’s current signal on NRSN?

LOPJLB’s latest quantitative signal on NeuroSense Therapeutics Ltd. (NRSN) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is NRSN in?

NeuroSense Therapeutics Ltd. (NRSN) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does NeuroSense Therapeutics Ltd. (NRSN) do?

NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyo…

Where is NeuroSense Therapeutics Ltd. based / listed?

NeuroSense Therapeutics Ltd. is based in IL, listed on NASDAQ.

NeuroSense Therapeutics Ltd. (NRSN)

COMPARE

Healthcare · Biotechnology · NASDAQ · IL

$3.82-6.14%Close

SELLCRISIS · day 22

[SCORES & PROFILE]

FUND: 2
VALUE: 7
GROWTH: 35
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-

GROSS

NET

[VALUATION]

P/E TTM-0.58

P/E FWD-

SECTOR PE20.33

INDUSTRY PE14.17

P/B-3.33

P/FCF-

EV/EBITDA-0.82

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.31

ND/EBITDA-

BETA1.58

NeuroSense Therapeutics Ltd. (NRSN)

Key stats

Prediction markets

FUNDAMENTALS

Company news